Entrepreneurs and start-ups in the biopharmaceutical and biotech space are always at a crossroads. Without extra capital to burn (who has that?), every decision needs to be made with the utmost clarity and data to back it.

Enter Carta, the partner built to help you succeed. Anthony Cimino, Head of Policy at Carta, Holli Heiles Pandol, Policy Counsel at Carta, and Amy Miller, Public Policy Director at Carta, break down the capital strategy your team needs to know about and offer a guide for navigating the policies that affect it.

Join us as we discuss:

• What tax credits you might be missing out on
• The importance of connecting stakeholders, customers, and policymakers
• What investment opportunities might be just under your nose